Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis.
about
Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosisRole of prostaglandins in neuroinflammatory and neurodegenerative diseasesOligomerization of Cu,Zn-Superoxide Dismutase (SOD1) by Docosahexaenoic Acid and Its Hydroperoxides In Vitro: Aggregation Dependence on Fatty Acid Unsaturation and Thiols.Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.Inflammation in ALS and SMA: sorting out the good from the evil.Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence.Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly.Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms.Role of zinc in ALS.Reduction of cytosolic phospholipase A2α upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis.Denervation induces cytosolic phospholipase A2-mediated fatty acid hydroperoxide generation by muscle mitochondriaPeroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease.Emerging drugs for amyotrophic lateral sclerosis.Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.Immunological aspects in amyotrophic lateral sclerosis.Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.A Genome-wide Expression Association Analysis Identifies Genes and Pathways Associated with Amyotrophic Lateral Sclerosis.4-Hydroxy-2-nonenal upregulates and phosphorylates cytosolic phospholipase A(2) in cultured Ra2 microglial cells via MAPK pathways.The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches.Cyclooxygenase-1 mediates prostaglandin E(2) elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1beta expression.Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis.Increased Expression of 15-Hydroxyprostaglandin Dehydrogenase in Spinal Astrocytes During Disease Progression in a Model of Amyotrophic Lateral Sclerosis.CDP-choline is not protective in the SOD1-G93A mouse model of ALS
P2860
Q24623266-13BA214C-35EC-4044-A3E4-36CCC56EBCDBQ26863534-D1C617A3-16A4-439B-A1A4-C376CBBE8B15Q30374274-322FAF04-D03F-43AB-8C7C-08D3292337C0Q33457162-CB482FAB-2940-40F1-A54B-BDE0D284FCECQ33500473-AB9F52B9-F8DA-4485-A978-D44155595809Q33664711-A5192433-67A4-459F-852D-048D4E374EF1Q34016411-9E20A792-10EC-4448-A1D7-55290ACAE5E2Q34998538-4C22FA48-3BDD-404B-83EA-D6FF319315FAQ36473605-B142623B-D73A-4C09-99E4-B9143A317CADQ36811555-DE1CB779-6151-43DC-8C19-5E745F19E277Q36835575-020BBF6A-8700-4653-B6C0-D3F4A0C97C7DQ36955096-95E170E6-8984-4318-A70C-134B9055016BQ37029870-E7C4C1E4-A048-4353-8305-E495E52AEBD6Q37157528-9B34A9BB-C5D9-4014-A629-298221BC195EQ37909351-50D5B987-9669-4CE3-8B90-6EFC3A6630ABQ38150127-CB0A4B04-203A-4357-ADDC-BE1FD04B763AQ38170060-A51214E7-A886-47FF-B0FB-A28E22EA83C1Q38542939-D4959546-FEE8-424C-A8E2-94F612244A9EQ38714588-16B5DAD7-9652-434B-998C-981FC5C7F25DQ39674504-65B4146C-28EC-4D11-99D0-836CE0AC5428Q41107984-FA8699C5-5A31-45AB-B06B-19457AE046FBQ42737833-E24C4078-5465-4A99-803B-CBF4A5206EFCQ50765060-6A2C8632-3F56-4E62-ABB9-D251558FF389Q53109419-28D7348A-CC6A-4C53-8309-7242B2F323B0Q58181343-EB9931C5-60E2-45AE-8F2B-E6A8612AAED3
P2860
Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Integrative role of cPLA with ...... amyotrophic lateral sclerosis.
@en
Integrative role of cPLA with ...... amyotrophic lateral sclerosis.
@nl
type
label
Integrative role of cPLA with ...... amyotrophic lateral sclerosis.
@en
Integrative role of cPLA with ...... amyotrophic lateral sclerosis.
@nl
prefLabel
Integrative role of cPLA with ...... amyotrophic lateral sclerosis.
@en
Integrative role of cPLA with ...... amyotrophic lateral sclerosis.
@nl
P2093
P2860
P1476
Integrative role of cPLA with ...... amyotrophic lateral sclerosis.
@en
P2093
Dong-Kug Choi
Junyu Chen
Khatuna Kipiani
M Flint Beal
Mahmoud Kiaei
Noel Y Calingasan
P2860
P304
P356
10.1111/J.1471-4159.2005.03024.X
P407
P577
2005-04-01T00:00:00Z